33

DAFTAR PUSTAKA

Abidullah, Hussain H., Shujat A., Kamal Z. and Ullah S., 2013,

Pharmacotherapeutical Study of Peptic Ulcer Disease, Impact Journal, 1 (3),

29–36.

Alfiawati N., 2014, Evaluasi Penggunaan Obat Pada Pasien Tukak Peptik Di

Instalasi Rawat Inap RSUP Dr. Soeradji Tirtonegoro Klaten Tahun 2014,

Skripsi, Fakultas Farmasi, Universitas Muhammadiyah Surakarta, Surakarta.

Alldredge B.K., Corelli R.L., Ernst M.E., Guglielmo B.J., Jacobson P.A., Kradjan

W.A. and Williams B.R., 2013, Gastrointestinal Disorders, Koda-Kimble

and Young’s Applied Therapeutics : The Clinical Use of Drugs, Wolters

Kluwer Lippincott Williams & Wilkins, pp. 669–679.

Al-marsoumi and Jabbo, 2013, Risk factors in perforated peptic ulcer disease :

Incidence and relation to morbidity and mortality, Mustansiriya Medical Journal, 12 (1), 35–44.

Ansari J.A., 2010, Drug Interaction and Pharmacist, Journal of young

pharmacists : JYP, 2 (3), 326–331.

Avunduk C., 2008, Manual Of Gastroenterology : Diagnosis and Therapy, Fourth

Edition., Wolters Kluwer Lippincott Williams & Wilkins, Philadelphia.

Baxter K., 2008, Stockley’s Drug Interactions, Eighth Edition., Pharmaceutical

Press, London.

Berardi R.R. and Welage L.S., 2008, Pharmacotherapi : A Pathophysiologic

Approach, dalam Gastrointestinal Disorders, Mc-GrawHill, New York, pp.

569–583.

British National Formulary, 2011, British National Formulary 61, dalam

Gastrointestinal System, BMJ Group and the Royal Pharmaceutical, London.

Chan W.H., Khin L.W., Chung Y.F.A. and Wong W.K., 2011, Randomized

Controlled Trial of Standard Versus High-dose Intravenous Omeprazole

After Endoscopic Therapy in High-risk Patients With Acute Peptic Ulcer

Bleeding, British Journal of Surgery Society Ltd, 98(5) Terdapat di:

https://www.ncbi.nlm.nih.gov/pubmed/21305536.

Cipolle R.J., Strand L.M. and Morley P.C., 1998, Pharmaceutical Care Practice,

McGraw-Hill: Health Professsions Division, United States of America.

Cipolle R.J., Strand L.M. and Morley P.C., 2004, Pharmaceutical Care Practice :

The Clinician’s Guide, Second Edition., Mc-GrawHill Companies.

34

Drug Administration and Control Authority, 2007, National Drug Formulary of

Ethiopia, 5–7. Terdapat di:

http://www.who.int/medicines/areas/coordination/ethiopia_formulary.

Desta Z., Soukhova N. V. and Flockhart D.A., 2001, Inhibition of cytochrome

P450 (CYP450) isoforms by isoniazid: Potent inhibition of CYP2C19 and

CYP3A, Antimicrobial Agents and Chemotherapy, 45 (2), 382–392.

Djojoningrat D., 2001, Dispepsia Fungsional, Dalam Buku Ajar Ilmu Penyakit

Dalam, Balai Penerbit FKUI, Jakarta, pp. 153–157.

Drepper M.D., Spahr L. and Frossard J.L., 2012, Clopidogrel and proton pump

inhibitors -where do we stand in 2012?, World journal of gastroenterology :

WJG, 18 (18), 2161–2171.

Faull R., 2007, Prescribing in Renal Disease, Australian Prescriber, 30 (1), 17–

20.

Food and Drug Administration, 2011, FDA Drug Safety Communication: Low

magnesium levels can be associated with long-term use of Proton Pump

Inhibitor drugs (PPIs), U.S. Department of Health and Human Services

Terdapat di: http://www.fda.gov/Drugs/DrugSafety/ucm245011.htm

[Diakses pada October 16, 2016].

Flockhart, 2001, Methods of Drug Interaction Studies, 5. Terdapat di:

http://www.nihs.go.jp/phar/pdf/DiGlEngFinal011209.

Halczli A. and Woolley A.B., 2013, Medication underdosing and

underprescribing: important issues that may contribute to polypharmacy and

poor outcomes, Formulary Journal Outcomes, 1–4.

Helmyati S., Rahmawati N.F., Purwanto and Yuliati E., 2014, Buku Saku

Interaksi Obat dan Makanan, Gajah Mada University Press, Yogyakarta.

Hirlan, 2001, Gastritis, Dalam Buku Ajar Ilmu Penyakit Dalam, Balai Penerbit

FKUI, Jakarta, pp. 127–131.

Kementrian Kesehatan Republik Indonesia, 2010, Profil Kesehatan Indonesia

Tahun 2009, Kementrian Kesehatan Republik Indonesia, Jakarta.

Kementrian Kesehatan Republik Indonesia, 2011, Pedoman Interpretasi Data

Klinik, Jakarta.

Joenoes N.Z., 2009, Ars Prescribendi : Resep yang Rasional, Airlangga

University Press, Surabaya.

Kigen G., Kimaiyo S., Nyandiko W., Faragher B., Sang E., Beatrice, Jakait, Owen

A., Back D., Gibbons S., Seden K. and Khoo S.H., 2011, Prevalence of

Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large

Kenyan Cohort, PLoS ONE, 6 (2), 2.

35

Kolesar J. and Vermeulen L., 2016, Top 300 Pharmacy Drug Cards, Mc Graw

Hill Education, New York.

Lacy C.F., Armstrong L.L., Goldman M.P. and Lance L.L., 2009, Drug

Information Handbook, 17th Edition., Lexi-Comp for American Pharmacists

Association.

Lockrey G. and Lim L., 2011, Peptic Ulcer Disease in Older People, Journal of

Pharmacy Practice and Research, 41 (1), 58–60.

Lucida H., Trisnawati R. and Suardi M., 2011, Analisis Aspek Farmakokinetika

Klinik Pasien Gagal Ginjal Pada IRNA Penyakit Dalam RSUP DR. M.

Djamil Padang Fakultas Farmasi Universitas Andalas Padang, Jurnal Sains

dan Teknologi Farmasi, 16 (2), 144–152.

Matsui H., Shimokawa O., Kaneko T., Nagano Y., Rai K. and Hyodo I., 2011,

The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-

induced mucosal injuries in stomach and intestine, J. Clin. Biochem. Nutr, 48

(2), 107–111.

Mohebbi L. and Hesch K., 2009, Stress ulcer prophylaxis in the intensive care

unit, Baylor University Medical Center Proceedings, 22 (4), 373–376.

Neal M.J., 2007, At a Glance : Farmakologi Medis, Edisi Kelima., Penerbit

Erlangga, Jakarta.

Nita Y., 2004, Manajemen Farmasi, Airlangga University Press, Surabaya.

Pharmaceutical Care Network Europe, 2006, PCNE Classification for Drug

Related Problem, Pharmaceutical Care Network Europe Foundation.

Priyanto, 2009, Farmakoterapi & Terminologi Medis, Penerbit : Lembaga Studi

dan Konsultasi Farmakologi (Leskonfi), Jakarta.

Sanusi I.A., 2011, Buku Ajar Gatroenterologi, Edisi Kesatu., InternaPublishing

Pusat Penerbitan Ilmu Penyakit Dalam, Jakarta Pusat.

Setiawati A., 2008, Farmakologi dan Terapi, edisi 5., Departemen Farmakologi

dan Terapeutik Fakultas Kedokteran - Universitas Indonesia, Jakarta.

Siddique R.A.H., 2014, Prevalence of Peptic Ulcer Disease Among the Patients

With Abdominal Pain Attending the Department of Medicine in Dhaka

Medical College Hospital, Bangladesh, IOSR Journal of Dental and Medical

Sciences, 13 (1), 5–9.

Tas I., Ulger B.V., Onder A., Kapan M. and Bozdag Z., 2015, Risk Factors

Influencing Morbidity and Mortality in Perforated Peptic Ulcer Disease,

Turkish Surgical Association.

36

Tatro D.S., 2012, Drug Interaction Facts 2012: The Authority on Drug

Interactions, Wolters Kluwer Health, California.

Thorsen K., Soreide J.A., Kvaloy J.T., Glomsaker T. and Soreide K., 2013,

Epidemiology of Perforated Peptic Ulcer: Age - and Gender Adjusted

Analysis of Incidence and Mortality, World Journal of Gastroenterology, 19

(3), 347–354.

Vanderhoff B.T. and Tahboub R.M., 2002, Proton pump inhibitors: An update,

American Family Physician, 66 (2), 273–278.

Veterans Affairs Pharmacy Benefits, 2005, Criteria for Use of High-dose Oral

Proton Pump Inhibitors, Terdapat di: http://www.pbm.va.gov [Diakses pada

October 28, 2016].

Wecker L., Crespo L.M., Dunaway G., Faingold C. and Watts S., 2010, Brody’s

Human Pharmacology Molecular to Clinical, Fifth Edition., Mosby Elsevier,

Canada.